Showing results (21-30 of 56) with videos related to
Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Circulating giant macrophages as a potential biomarker of solid tumorsDaniel L Adams, Stuart S Martin, R Katherine Alpaugh, et al.Breast Cancer Research : BCR|December 3, 2020
Immune phenotype of patients with stage IV metastatic inflammatory breast cancerSandra V Fernandez, Alexander W MacFarlane, Mowafaq Jillab, et al.Oncoimmunology|August 17, 2017
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptorsAlexander W MacFarlane, Mowafaq Jillab, Mitchell R Smith, et al.Gynecologic Oncology|July 15, 2011
Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial ovarian and primary peritoneal malignancies: a Gynecologic Oncology Group studyKian Behbakht, Michael W Sill, Kathleen M Darcy, et al.Head & Neck|April 1, 2025
Phase II Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckAarti Bhatia, Ranee Mehra, Jessica Bauman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2004
Individualized patient dosing in phase I clinical trials: the role of escalation with overdose control in PNU-214936Jonathan D Cheng, James S Babb, Corey Langer, et al.RSC Advances|November 3, 2017
Precision Microfilters as an all in one System for Multiplex Analysis of Circulating Tumor CellsDaniel L Adams, R Katherine Alpaugh, Stuart S Martin, et al.BMC Cancer|June 20, 2019
Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancerTim N Beck, Yanis A Boumber, Charu Aggarwal, et al.American Journal of Clinical Oncology|May 12, 2010
Phase II and coagulation cascade biomarker study of bevacizumab with or without docetaxel in patients with previously treated metastatic pancreatic adenocarcinomaIgor A Astsaturov, Neal J Meropol, R Katherine Alpaugh, et al.Pancreas|March 12, 2016
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic AdenocarcinomaEfrat Dotan, R Katherine Alpaugh, Karen Ruth, et al.Pageof 6